Immediate Impact

6 from Science/Nature 74 standout
Sub-graph 1 of 21

Citing Papers

CDK4 and CDK6 kinases: From basic science to cancer therapy
2022 StandoutScience
Metal–Organic Frameworks in Heterogeneous Catalysis: Recent Progress, New Trends, and Future Perspectives
2020 Standout
2 intermediate papers

Works of Chris Liang being referenced

SU14813: a novel multiple receptor tyrosine kinase inhibitor with potent antiangiogenic and antitumor activity
2006
Discovery of 5-[5-Fluoro-2-oxo-1,2- dihydroindol-(3Z)-ylidenemethyl]-2,4- dimethyl-1H-pyrrole-3-carboxylic Acid (2-Diethylaminoethyl)amide, a Novel Tyrosine Kinase Inhibitor Targeting Vascular Endothelial and Platelet-Derived Growth Factor Receptor Tyrosine Kinase
2003

Author Peers

Author Last Decade Papers Cites
Chris Liang 461 474 569 36 1.1k
Ulrike Tontsch-Grunt 411 616 644 19 1.4k
G. Dark 465 326 549 28 1.4k
Sharon K. Rudolph 300 255 489 12 942
G. Mangold 436 132 657 46 1.2k
Haitian Quan 651 375 485 30 1.3k
Anna Fioravanti 398 190 325 38 888
Zhenfang Du 392 265 747 34 1.3k
Clive Morris 629 465 729 38 1.3k
Kazuhide Nakamura 245 131 595 26 1.0k
Toshiyuki Isoe 383 145 617 29 921

All Works

Loading papers...

Rankless by CCL
2026